AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
14.41
+0.79 (5.80%)
At close: Mar 9, 2026, 4:00 PM EDT
14.43
+0.02 (0.14%)
After-hours: Mar 9, 2026, 4:04 PM EDT
AgomAb Therapeutics NV Market Cap
AgomAb Therapeutics NV has a market cap or net worth of $702.3 million as of March 9, 2026.
Market Cap
702.30M
Enterprise Value
537.68M
1-Year Change
n/a
Ranking
Category
Stock Price
$14.41
Market Cap Chart
Since the IPO on February 6, 2026, AgomAb Therapeutics NV's market cap has decreased from $779.79M to $702.30M, a decrease of -9.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 703.27M | 5.95% |
| Mar 6, 2026 | 663.79M | -4.15% |
| Mar 5, 2026 | 692.55M | -3.20% |
| Mar 4, 2026 | 715.46M | -7.67% |
| Mar 3, 2026 | 774.91M | -1.91% |
| Mar 2, 2026 | 790.02M | 1.19% |
| Feb 27, 2026 | 780.76M | 0.06% |
| Feb 26, 2026 | 780.28M | -0.62% |
| Feb 25, 2026 | 785.15M | 0.75% |
| Feb 24, 2026 | 779.30M | 3.83% |
| Feb 23, 2026 | 750.55M | -0.65% |
| Feb 20, 2026 | 755.42M | -0.70% |
| Feb 19, 2026 | 760.78M | 6.19% |
| Feb 18, 2026 | 716.43M | -2.97% |
| Feb 17, 2026 | 738.36M | -1.24% |
| Feb 13, 2026 | 747.62M | -2.04% |
| Feb 12, 2026 | 763.22M | -2.13% |
| Feb 11, 2026 | 779.79M | 2.89% |
| Feb 10, 2026 | 757.86M | -0.38% |
| Feb 9, 2026 | 760.78M | -2.44% |
| Feb 6, 2026 | 779.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prime Medicine | 715.40M |
| Replimune Group | 710.95M |
| ProKidney | 703.95M |
| Jade Biosciences | 702.26M |
| Theravance Biopharma | 696.75M |
| Alto Neuroscience | 651.00M |
| MiMedx Group | 650.72M |
| Zura Bio | 644.20M |